| Basics |
Alkermes plc Ordinary Shares
Alkermes PLC is a fully integrated, biopharmaceutical company. It applies its scientific expertise and proprietary technologies to research, develop and commercialize pharmaceutical products to address unmet medical needs of patients.
|
| IPO Date: |
August 1, 1991 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$4.45B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.49 | 1.87%
|
| Avg Daily Range (30 D): |
$0.48 | 1.58%
|
| Avg Daily Range (90 D): |
$0.44 | 1.40%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.06M |
| Avg Daily Volume (30 D): |
1.33M |
| Avg Daily Volume (90 D): |
1.28M |
| Trade Size |
| Avg Trade Size (Sh.): |
121 |
| Avg Trade Size (Sh.) (30 D): |
58 |
| Avg Trade Size (Sh.) (90 D): |
63 |
| Institutional Trades |
| Total Inst.Trades: |
13,147 |
| Avg Inst. Trade: |
$2.48M |
| Avg Inst. Trade (30 D): |
$4.63M |
| Avg Inst. Trade (90 D): |
$3.93M |
| Avg Inst. Trade Volume: |
.09M |
| Avg Inst. Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.07M |
| Avg Closing Trade (30 D): |
$12.21M |
| Avg Closing Trade (90 D): |
$11.07M |
| Avg Closing Volume: |
172.13K |
|
|
|
|
| Financials |
| |
TTM |
TTM 2024 |
Q4 2024 |
|
Basic EPS
|
$-1.07
|
$2.22
|
$.9
|
|
Diluted EPS
|
$-1.07
|
$2.17
|
$.87
|
|
Revenue
|
$ 2.12M
|
$ 1.56B
|
$ 429.99M
|
|
Gross Profit
|
$
|
$ 1.31B
|
$ 367.87M
|
|
Net Income / Loss
|
$ -57.96M
|
$ 367.07M
|
$ 146.5M
|
|
Operating Income / Loss
|
$ -64.9M
|
$ 420.64M
|
$ 162.69M
|
|
Cost of Revenue
|
$
|
$ 245.33M
|
$ 62.12M
|
|
Net Cash Flow
|
$ -47.87M
|
$ -166.32M
|
$ -105.15M
|
|
PE Ratio
|
|
|
|
|
